Form 4: ClearPoint Neuro Director Acquires Shares Through Compensation Plan

ClearPoint Neuro, Inc. Director R. John Fletcher acquired 484 shares of common stock on July 1, 2025, as part of his non-employee director compensation.

Summary

• R. John Fletcher, a Director of ClearPoint Neuro, Inc. (CLPT), acquired 484 shares of common stock.
• The transaction occurred on July 1, 2025.
• The shares were acquired at a price of $11.94 per share.
• These shares were issued as payment for fees owed to Mr. Fletcher under the company's Non-Employee Director Compensation Plan, as amended and restated.
• The issuance was pursuant to the issuer's Sixth Amended and Restated 2013 Incentive Compensation Plan.
• The shares were issued at the closing price of ClearPoint Neuro, Inc.'s common stock on June 30, 2025.
• Following this transaction, R. John Fletcher beneficially owns 115,975 shares of ClearPoint Neuro common stock directly.

Sentiment

Score: 6

Explanation: The transaction reflects a routine compensation-related acquisition of shares by a director, which is a neutral event but can be viewed slightly positively as it increases insider ownership and aligns interests.

Positives

• Director R. John Fletcher increased his direct beneficial ownership in ClearPoint Neuro, Inc. by 484 shares, demonstrating continued alignment with shareholder interests.
• The shares were issued as part of a pre-existing and structured compensation plan for non-employee directors.

Future Outlook

NA

Industry Context

This Form 4 filing represents a routine insider transaction where a director receives equity as part of their compensation, a common practice across various industries to align management and director interests with shareholders. It does not provide specific insights into broader industry trends for medical devices or neuro-navigation.

Related Party Transactions

• The acquisition of shares by Director R. John Fletcher is a related party transaction, as it involves the issuance of equity to an insider as part of their compensation plan.

Stakeholder Impact

• Shareholders: Increased direct ownership by a director, potentially signaling continued confidence and aligning interests.

Key Dates

Keywords

ClearPoint Neuro, CLPT, Form 4, Insider Transaction, Director Compensation, Stock Acquisition, Equity Compensation, R. John Fletcher